Unicyte AG Email Format
Biotechnology ResearchNidwalden, Switzerland2-10 Employees
Unicyte AG is a biotechnology research company focused on regenerative medicine, developing stem cell-based therapies as a new class of human therapeutics. It has translated its discoveries into a broad pre-clinical pipeline and aims to advance toward human clinical studies for diseases with high unmet medical need. Founded in 2015 as an independent affiliate of Fresenius Medical Care, the company is headquartered in Oberdorf, Nidwalden, Switzerland, and operates with a small, specialized team. Within the biotechnology sector, Unicyte emphasizes liver stem cell biology and nano-extracellular vesicle research to address kidney and liver diseases, diabetes, and cancer. A notable recent development is the 2022 submission of a European Clinical Trial Application for a Phase 2 study of its liver stem cell therapy in pediatric early-onset urea cycle disorders.